Bottom line
What is IMANX's expense ratio?
IMANX's expense ratio is 0.99%, or about $99 a year on every $10,000 invested. That is more expensive than 63% of large blend funds we track (median 0.83%). It has no front-end sales load.
Updated Sep 24, 2026
IMANX fee table
| Net expense ratio | 0.99% |
|---|---|
| Gross expense ratio | 1.29% |
| Management fee | 1% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.29% |
| Fee waiver / reimbursement | -0.3% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Sep 24, 2026
What IMANX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IMANX | $101 | $379 | $679 | $1,530 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.99% expense ratio costs roughly $54,900 in lost growth, versus about $46,700 for the median large blend fund (0.83%).
Cheaper alternatives to IMANX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.